The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Akt Enhances Mdm2-mediated Ubiquitination and Degradation of p53
Open accessAbstract
p53 plays a key role in DNA damage-induced apoptosis. Recent studies have reported that the phosphatidylinositol 3-OH-kinase-Akt pathway inhibits p53-mediated transcription and apoptosis, although the underlying mechanisms have yet to be determined. Mdm2, a ubiquitin ligase for p53, plays a central role in regulation of the stability of p53 and serves as a good substrate for Akt. In this study, we find that expression of Akt reduces the protein levels of p53, at least in part by enhancing the degradation of p53. Both Akt expression and serum treatment induced phosphorylation of Mdm2 at Ser186. Akt-mediated phosphorylation of Mdm2 at Ser186 had little effect on the subcellular localization of Mdm2. However, both Akt expression and serum treatment increased Mdm2 ubiquitination of p53. The serum-induced increase in p53 ubiquitination was blocked by LY294002, a phosphatidylinositol 3-OH-kinase inhibitor. Moreover, when Ser186 was replaced by Ala, Mdm2 became resistant to Akt enhancement of p53 ubiquitination and degradation. Collectively, these results suggest that Akt enhances the ubiquitination-promoting function of Mdm2 by phosphorylation of Ser186, which results in reduction of p53 protein. This study may shed light on the mechanisms by which Akt promotes survival, proliferation, and tumorigenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We and other groups (58) did not observe significant changes in the subcellular localization of Mdm2 when PKB was activated by a variety of stimuli (data not shown).”
From Stabilization of Mdm2 via Decreased Ubiquitination Is Mediated by Protein Kinase B/Akt-dependent Phosphorylation (2004) · cites this paper as [58]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Self-citationAkt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Regulation of Cell Death Protease Caspase-9 by Phosphorylation
Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., & Reed, J. C. (1998) · Science · doi:10.1126/science.282.5392.1318 · Cited by 2,481
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Flagged first, then by citations
Research works printed but not linked: 4
- Chen, 1993, Mol. Cell. Biol., 13, 4107
- Mayo, 1997, Cancer Res., 57, 5013
- Bellacosa, 1991, Science, 254, 274
- Kern, 1992, Science, 256, 827, 10.1126/science.256.5058.827 · DOI
Cited by
Sorted by citations
Items 501–600 of 617
Campbell, J. M., Lane, M., Vassiliev, I. M., & Nottle, M. B. (2013) · BioMed Research International · doi:10.1155/2013/150901 · Cited by 2
Oscillations and DNA Repair in a Spatio-Temporal Model of the p53 Signalling Pathway
Terry, A. J. (2014) · Mathematical Modelling of Natural Phenomena · doi:10.1051/mmnp/20149307 · Cited by 2
“It has been found that active Akt, by phosphorylating Mdm2, promotes Mdm2-mediated degradation of p53 [27].”
BackgroundMolecular Signaling in Oral Cancer Invasion and Metastasis
Chang, I., Rehman, A. O., & Wang, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-27647-2_5 · Cited by 2
“Akt-mediated phosphorylation of MDM2 at serine 186 increases MDM2 ubiquitination of p53, which results in degradation of the p53 protein [ 83 , 84 ].”
BackgroundProliferation and Differentiation Programs of Developing B Cells
Werner, M., & Jumaa, H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397933-9.00006-0 · Cited by 3
Tribbles Gene Expression Profiles in Colorectal Cancer
Fernandes, M. T., Yassuda, V., Bragança, J., Link, W., Ferreira, B. I., & Sousa‐Coelho, A. L. D. (2021) · Gastrointestinal Disorders · doi:10.3390/gidisord3040021 · Cited by 2
“TP53 is a tumor suppressor gene known to be regulated by PI3K/AKT signaling [66], and TP53 mutations are common in human cancers.”
BackgroundThe p53-Mdm2 Loop: A Critical Juncture of Stress Response
Levav-Cohen, Y., Goldberg, Z., Alsheich-Bartok, O., Zuckerman, V., Haupt, S., & Haupt, Y. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_5 · Cited by 2
The role of time delays in P53 gene regulatory network stimulated by growth factor
Dai, C., Liu, H., & Yan, F. (2020) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2020213 · Cited by 2
McDonald, G. T. (2008) · QSpace (Queen's University Library) · Cited by 2
Wen, L., Cai, K., Fan, C., Jin, L., Fu, G., & Yan, J. (2025) · Molecular & Cellular Toxicology · doi:10.1007/s13273-025-00555-w · Cited by 1
“Activating AKT signaling has been demonstrated to attenuate p53 signaling, thereby reducing apoptosis (Ogawara et al. 2002).”
Kazemzadeh, M., Safaralizadeh, R., Mokhtarzadeh, A. A., & Feizi, M. A. H. (2025) · Human Gene · doi:10.1016/j.humgen.2025.201499 · Cited by 1
Mitochondrial translocation of MDM2 and TFAM reprograms metabolism in treatment-refractory cancers
Eu, J. Q., Salleh, N. A. B. M., Hirpara, J. L., Ohi, N., Omori, E., Tan, T. Z., Seet, J. E., Hue, S. S., Chan, S. J., Lim, D. X. Y., et al. (2026) · npj Precision Oncology · doi:10.1038/s41698-025-01257-1 · Cited by 1
“Given that Ser166 is a known AKT target 23,24 , and that Ser395 is driven by ATM to activate p53-driven apoptosis 23,25,26 , we hypothesized that PI3K/ AKT activation underlies MDM2 phosphorylation in resistant models.”
Zhou, L. (2015) · Scholarship@Western (Western University) · Cited by 1
Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms
Lasho, T. L., Pardanani, A. D., Tefferi, A., & Smith, D. I. (2014) · Leukemia · doi:10.1038/leu.2014.117 · Cited by 1
Attempt at a systemic outlook on aging and carcinogenesis
Piwowar, M. W., Dygut, J. M., Piwowar, P., Konieczny, L., & Roterman, I. (2014) · Bio-Algorithms and Med-Systems · doi:10.1515/bams-2014-0012 · Cited by 1
“A pro-survival state exists under low concentrations of p53 and high concentrations of AKT, while the reverse is true of pro-apoptotic conditions [69] (see Figure 11).”
BackgroundEvidence of a tumour suppressive function of E2F1 genes in human breast cancer
Mokbel, K., Worku, D. A., & Jiang, W. G. (2008) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2008.06.181 · Cited by 1
Xu, T. (2015) · International Journal of Sciences · doi:10.18483/ijsci.796 · Cited by 1
“HIE can lead to DNA damage and mutation of neurons, and the gene expression of mdm2 in neurons has been reported[2].”
BackgroundKoul, B. (2019) · Springer eBooks · doi:10.1007/978-981-32-9147-8_1 · Cited by 1
Li, Z., Pan, G., Zhong, M., Zhang, L., Yu, X., Zha, J., & Xu, B. (2023) · International Journal of Toxicology · doi:10.1177/10915818231178693 · Cited by 1
PI3K/Akt Signaling Pathway in Normal and Malignant Cells
Yothaisong, S., & Loilome, W. (2012) · Srinagarind Medical Journal (SMJ) - ศรีนครินทร์เวชสาร · Cited by 1
Bonilla-Ramírez, L., Jiménez-Del-Río, M., & Velez‐Pardo, C. (2017) · IATREIA · doi:10.17533/udea.iatreia.v30n2a02 · Cited by 1
“Indeed, it has been shown that Akt enhances both the ubiquitinizationpromoting function of Mdm2 (murine double minute) and Mdm2 protein stabilization by phosphorylation of Ser186, Ser166, and Ser188, which results in the reduction of p53 protein (44, 45).”
BackgroundMechanism of cytotoxic activity of chalcone derivatives against K562 leukemia cell lines
Novilla, A., Astuti, I., Mustofa, M., Jumina, J., & Suwito, H. (2017) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · doi:10.19106/jmedsci004904201701 · Cited by 1
Majewska, A., Brodaczewska, K. K., Filipiak-Duliban, A., & Kiéda, C. (2023) · Biochemistry and Cell Biology · doi:10.1139/bcb-2023-0047 · Cited by 1
Tecleab, A. (2013) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1
PI3K/PTEN signaling in liver diseases
Fort, A., Calo, N., Portius, D., Bourgoin, L., Peyrou, M., & Foti, M. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch21 · Cited by 1
Interplay of 14-3-3 Family of Proteins with DNA Damage-Regulated Molecules in Checkpoint Control
Lee, M., Yeung, S. J., & Yang, H.-Y. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_5 · Cited by 1
Dynamics of the p53 response to ionizing and ultraviolet radiationPreprint
Fedak, E. A., Adler, F. R., Young, E. L., Abegglen, L. M., & Schiffman, J. D. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/367995 · Cited by 1
“PTEN sets off a chain of events that sequester newly transcribed Mdm2 in the 200 cytosol [32,33].”
BackgroundA Roadmap to Immunotherapy: Lesson from the Hallmarks and Signaling Pathways of CancerPreprint
Derakhshani, A., Rostami, Z., Safarpour, H., Taefehshokr, S., Tabrizi, N. J., Shadbad, M. A., Kooshkaki, O., Astamal, R. V., Argentiero, A., Singh, P. K., et al. (2020) · Preprints.org · doi:10.20944/preprints202011.0034.v1
Agamia, N., Mulla, K. F. E., El‐Sayed, N., Ghazala, R. A., Maksoud, R. A. E., Elmonem, E. A., Talat, E., Zaki, I. A., Sabah, R. M., & Melnik, B. C. (2022) · Research Square · doi:10.21203/rs.3.rs-1609874/v1 · Cited by 1
Nam, G., Kim, B., & Kim, Y. (2024) · Preprints.org · doi:10.20944/preprints202405.0404.v1
Bertacchini, J. (2013) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/5155
Dysregulation of energy metabolism in obesity and its implications for cancer
Battaglia, L., DeStefano, M. A., Hoffman, A. R., & Abali, E. E. (2016) · Journal of Pediatric Biochemistry · doi:10.3233/jpb-2012-00055
Youssef, A. (2014) · Scholarship@Western (Western University)
Programmed Cell Death in T Cell Development
Nancy, Q., & Troy, A. (2013) · InTech eBooks · doi:10.5772/48607 · Cited by 1
Towards an understanding of protein kinase B (PKB/Akt) function in mouse development
Yang, Z. (2004) · edoc (University of Basel) · doi:10.5451/unibas-003352888
Festa, L. (2011) · Università degli Studi di Napoli Federico II · doi:10.6092/unina/fedoa/8739
Negative Regulatory Mechanisms Underlying EPO Receptor Signaling and Erythropoiesis
Richmond, T. D. (2010) · TSpace (University of Toronto)
Statin-induced cellular effects mediated by the P2X7 receptor
Mistafa, O. (2009) · Figshare
THE NOVEL UPSTREAM REGULATOR OF FBXW7
Shin, J. (2014) · Digital Commons-TMC (Texas Medical Center)
Valladares, S. A. D., & Abanto, A. S. A. (2014) · International journal of odontostomatology · doi:10.4067/s0718-381x2014000200016
Glycogen Synthase Kinase 3 is Required for Optimal AKT Activation
Bruno, D. S. (2011) · Digital Commons-TMC (Texas Medical Center)
ESTUDO DO EFEITO NEUROPROTETOR DA DULOXETINA
Engel, D. F. (2013) · Americanae (AECID Library)
The p53 homolog p63 modulates acute and chronic damage in irradiated salivary glands
Mitchell, G. C. (2010) · UA Campus Repository (The University of Arizona)
Mdm2 phosphorylations : Characterization and applications
Malmlöf, M. (2007) · Figshare
The Role and Regulation of the Phosphatase PPM1D in Chemoresistant Gynecological Cancers
Ali, A. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-3512
THE ATTENUATION OF THE P53 RESPONSE TO DNA DAMAGE IN RODENT LIVER PRENEOPLASTIC ENZYME- ALTERED FOCI
Finnberg, N. K. (2003) · Figshare
cancer: cytoplasmic delocalization induced by the protein kinase Akt"
Motti, M. L. (2005)
Impact of type 1 diabetes on cardiac fibroblast activation
Shamhart, P. E., Luther, D. J., Hodson, B. R., Koshy, J. C., Ohanyan, V. A., & Meszaros, J. G. (2009)
p53, A NOVEL MOLECULAR TARGET OF URSODEOXYCHOLIC ACID IN MODULATING HEPATOCYTE APOPTOSIS
Farmácia, F. D. (2008)
Mdm, P. (2006)
Molecular Mechanisms Underlying the Oncogenic Function of SS18 and SSX
D’Arcy, P. (2008) · Figshare
Franke, T. F., & Berwick, D. C. (2005) · Springer eBooks · doi:10.1007/3-540-27194-5_20
Bentley, V. L. (2016) · DalSpace (Dalhousie University)
Park, H. (2008) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3hq403v
Characterization of the Ubiquitin/Nedd8 E3 ligase activity of the Mdm2/MdmX complex
Singh, R. K. (2007) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Regulación de la proteína quinasa Akt por conjugación a SUMO
Risso, G. (2013) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Huyghe, L. (2008) · Ghent University Academic Bibliography (Ghent University)
Aurora kinases in cancer: an opportunity for targeted therapy
Sehdev, V., Dar, A. A., & El-Rifai, W. M. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.024
Grochola, L. F., Zerón-Medina-Cuairán, J., Repapi, E., Finlayson, A. E. T., Cai, Y., Atwal, G. S., & Bond, G. L. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3676-8_2
Changing the balance in apoptosis: key to enhance cisplatin sensitivity of testicular cancer
Koster, R. (2010) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Combination Therapeutic Strategies Targeting Growth and Metabolic Pathways in Prostate Cancer
Canatsey, R. D. (2016) · UA Campus Repository (The University of Arizona)
Lei, H., Velez, G., Kazlauskas, A., & Eye, S. (2011)
Letienne, J. (2011) · Repository KITopen (Karlsruhe Institute of Technology) · doi:10.5445/ir/1000024812
“Mdm2 is highly regulated though many type of post-translational modifications such as ubiquitination, phosphorylation or sumoylation that have a positive or a negative impact on its ability to influence p53 activity (Maya et al., 2001; Ogawara et al., 2002; Meek et al., 2003).”
BackgroundThe Role of PIK3CA in Cisplatin Resistance of Cervical Cancer
Merry, C. D. (2016) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/28345
Investigating the Role of PHIP1 in Breast Cancer
Lee, C. M. (2013) · TSpace (University of Toronto)
Husaini, R. (2014) · Bradford Scholars (University of Bradford)
ENHANCING RADIATION SENSITIVITY IN NON-SMALL CELL LUNG CANCER
Wang, Y. (2018) · Digital Commons-TMC (Texas Medical Center)
Der Einfluss westlicher Ernährung
Melnik, B. C. (2019) · Der Deutsche Dermatologe · doi:10.1007/s15011-019-2434-4
Dysfunction and Death of Pancreatic Beta Cells in Type 2 Diabetes
Ortega‐Camarillo, C. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_12
The role of NFκB in glucose import and survival of B-cell lymphomas
Sommermann, T. G. (2012) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg)
Xing, Y., Li, Y., Rowse, M., Wu, C.-G., Bravos, A. P., Ivarsson, Y., & Strack, S. (2021) · Research Square · doi:10.21203/rs.3.rs-372534/v1
Pou5f1 Post-translational Modifications Modulate Gene Expression and Cell Fate
Campbell, P. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-6280
Bánfalvi, G. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9561-0_4
Sensitivierung von Sarkomzellen gegenüber Doxorubizin
Marklein, D. (2012) · doi:10.53846/goediss-1502
Chamovitz, D. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718487977.793546255
Erratum to: The 2014 Beatson international cancer conference: powering the cancer machine
Kamphorst, J. J., & Murphy, D. J. (2014) · Cancer & Metabolism · doi:10.1186/s40170-014-0127-8
Dysfunction and Death of Pancreatic Beta-Cells in Type 2 Diabetes
Ortega‐Camarillo, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_13
Maiuthed, A., Chanvorachote, P., Schneider-Stock, R., & Eichler, J. (2018) · doi:10.58837/chula.the.2018.436
Xu, Z., Zhou, H., Luo, Y., Li, N., & Chen, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28412
“Interestingly, Akt enhances MDM2-mediated ubiquitination and degradation of p53 [59 – 61].”
Background37 kDa LRP::FLAG enhances telomerase activity and reduces ageing markers in vivo
Otgaar, T. C., Bernert, M., Morris, G., Baichan, P., Bignoux, M. J., Letsolo, B. T., Weiss, S. F. T., & Ferreira, E. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05593-0
“5 b, Table to both telomere-dependent and -independent senescence, where its accumulation, especially within mice, has been linked to progression of the ageing phenotype [ 57 , 66 ].”
Common Signaling Pathways in Cancer and Alzheimer's Disease May Point to New Treatments
Wu, C., Jiang, L., Zhong, Y., & Liu, Z. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266340314250303003647
Wu, Y., Li, X., Lin, Y., Chen, Y., Xin, N., Hong, D., Wei, J., Li, H., Guo, T., Fan, L., et al. (2025) · Cancer Biology & Therapy · doi:10.1080/15384047.2025.2589678
“9,10 Importantly, our data extend this model by showing that stabilized E2F1 directly enhances NCAPD2 transcription, thereby establishing a self-reinforcing NCAPD2-AKT/MDM2-E2F1 loop.”
Qian, H., Wang, B., Zhang, L., Li, J., Huang, X.-X., Liu, B., Zhao, Y., & Wang, M. (2025) · Medicine · doi:10.1097/md.0000000000046660 · Cited by 1
“[48] In specific NSCLC subpopulations, the EML4-ALK fusion gene maintains the activation of the JAK-STAT pathway by upregulating antia-poptotic proteins (such as BCL-2 and MCL-1) through STAT3/5 phosphorylation.”
Novel concepts in MDM2 protein regulation
Worrall, E. G. (2009) · ERA
Huang, H., Park, S., Zhang, H., Park, S., Kwon, W., Kim, E., Zhang, X., Jang, S., Yoon, D. H., Choi, S.-K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14344414
Huang, H., Park, S., Zhang, H., Park, S., Kwon, W., Kim, E., Zhang, X., Jang, S., Yoon, D. H., Choi, S.-K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14344420
Huang, H., Park, S., Zhang, H., Park, S., Kwon, W., Kim, E., Zhang, X., Jang, S., Yoon, D. H., Choi, S.-K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14344408
Chen, Y., Dong, L., Deng, F., Cao, Y., Fu, Y., Zhu, M., Qin, G., Schultz, D. R., Shekh, K., & Tang, S. (2021) · Figshare · doi:10.6084/m9.figshare.15179362
Huang, H., Park, S., Zhang, H., Park, S., Kwon, W., Kim, E., Zhang, X., Jang, S., Yoon, D. H., Choi, S.-K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14344411
Huang, H., Park, S., Zhang, H., Park, S., Kwon, W., Kim, E., Zhang, X., Jang, S., Yoon, D. H., Choi, S.-K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14344417
Huang, H., Park, S., Zhang, H., Park, S., Kwon, W., Kim, E., Zhang, X., Jang, S., Yoon, D. H., Choi, S.-K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14344423
Kobyakova, M. I., Lomovskaya, Y. V., Krasnov, K. S., Odinokova, I. V., Мещерякова, Е. Ю., Ermakov, A. M., Didenko, A. S., Сенотов, А. С., Fadeeva, I. S., & Фадеев, Р. С. (2026) · Biochemistry (Moscow) · doi:10.1134/s000629792560276x
“Alternative activation of the Akt signaling pathway upon FLT3 inhibition could suppress the p38-MAPK pathway [84, 85] and the p53-dependent cascade through phosphorylation of MDM2 [86], as well as contribute to activation of the ErbB signaling pathway [87, 88].”
Rôle pro-tumorigénique de HACE1 dans le mélanome
Hachem, N. E. (2017) · theses.fr (ABES) · doi:10.70675/c29467dezf843z4a4cz91a8z8b39a51c97c6
Metadata
- Authors
- Ogawara, Y., Kishishita, S., Obata, T., Isazawa, Y., Suzuki, T., Tanaka, K., Masuyama, N., & Gotoh, Y.
- Affiliations
- Institute for Quantitative Biosciences, The University of Tokyo (JP)
- Tokushima University (JP)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Japan Science and Technology Agency (JP)
- Corresponding author
- Gotoh, Yukiko
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 277
- Issue
- 24
- Pages
- 21843-21850
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2027217537
- Semantic Scholar
- bca1d1791eb8e2056d050c2ab2b91129d0d06de7
- Cited by
- 617
- References
- 60
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 11 · 2023: 19 · 2022: 19 · 2021: 34 · 2020: 29 · 2019: 28 · 2018: 33 · 2017: 31 · 2016: 36 · 2015: 28 · 2014: 35 · 2013: 43 · 2012: 29
- FWCI
- 8.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- Akt, MDM2, p53, ubiquitination, protein degradation, PI3K/Akt signaling, p53 stabilization, LY294002, carcinogenesis, apoptosis
- MeSH terms
- Cell Survival, Chromones, Dose-Response Relationship, Drug, Enzyme Inhibitors, Humans, Microscopy, Fluorescence, Morpholines, Nuclear Proteins, Phosphorylation, Plasmids, Precipitin Tests, Protein Binding, Proto-Oncogene Proteins, Recombinant Proteins, RNA, Messenger, Serine, Subcellular Fractions, Time Factors, Tumor Cells, Cultured, Blotting, Western, Retroviridae Proteins, Oncogenic, Tumor Suppressor Protein p53, Apoptosis, Protein Serine-Threonine Kinases, Phosphatidylinositol 3-Kinases, Reverse Transcriptase Polymerase Chain Reaction, Ubiquitin, Proto-Oncogene Proteins c-akt, Oncogene Protein v-akt, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review